Johnson & Johnson (NYSE:JNJ) will begin trading ex-dividend on November 23, 2020. The quarterly dividend payment of $ 1.01 per share is scheduled to be paid on December 8, 2020. The dividend yield based on the latest trading day closing price was 2.75 percent. Shareholders who purchased JNJ shares prior to the ex-dividend date are eligible for the cash dividend payment.
Dividends History
wpDataTable with provided ID not found!Click Here For More Historical Dividends Of Johnson & Johnson
Johnson & Johnson recently reported third quarter financial results on October 13, 2020, before market open, research and developer of healthcare products revealed income for the third quarter of $ 2.20 per share, from the revenue of $ 21,082.00 million. The quarterly earnings surged 3.77 percent while revenues grew 1.70 percent compared with the same quarter last year.
The consensus estimates are income of $ 1.98 per share from $ 20200.00 million in revenue. The bottom line results beat street analysts by $ 0.22 or 11.11 percent, at the same time, top line results outshined analysts by $ 882.00 million or 4.37 percent.
Stock Performance
Shares of Johnson & Johnson traded low $ -0.23 or -0.16 percent on Thursday, reaching $ 147.14 with volume of 7.34 million shares. Johnson & Johnson has traded high as $ 147.46 and has cracked $ 145.59 on the downward trend
According to the previous trading day, closing price of $ 147.14, representing a 35.00 % increase from the 52 week low of $ 109.16 and a 6.13 % decrease over the 52 week high of $ 157.00.
The company has a market capital of $ 387.35 billion and is part of the Healthcare sector and Drug Manufacturers – Major industry.
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSONS brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSONS Adult, LE PETITE MARSEILLAIS, NEUTROGENA, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand.
